Abstract #3946

CEST MRI of 3-O-Methyl-D-Glucose uptake and accumulation in brain tumors

Akansha Ashvani Sehgal^1,2, Yuguo Li^1,2, Bachchu Lal³, Nirbhay N Yadav^1,2, Xiang Xu^1,2, Jiadi Xu^1,2, John Laterra³, and Peter C. M van Zijl^1,2

¹Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, ²F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, United States, ³Department of Neurology, Oncology, and Neuroscience, The Johns Hopkins Medicine, and The Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD, United States

Glucose weighted chemical exchange saturation transfer (CEST) imaging has garnered a lot of interest in the past few years as it can be a safe alternative to gadolinium contrast based MRI for tumor diagnosis. 3-O-methyl glucose (3-OMG) is a structural analog of glucose which, because of its apparent non-toxicity and its property to not get metabolized, has been shown to be another promising CEST contrast agent. Here we explore its application as a CEST contrast agent for assessing brain tumors.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.